Replies to post #237915 on Biotech Values

[DewDiligence]

ABBV raised_US_list_price_of Botox 3.6% on 7/1/21:

https://www.fiercepharma.com/pharma/sanofi-bms-allergan-lilly-and-others-join-growing-list-pharma-s-july-price-hikes-report

[DewDiligence]

2Q21 worldwide Botox sales=$1.19B, +18% QoQ, +127% YoY*:

https://news.abbvie.com/news/press-releases/abbvie-reports-second-quarter-2021-financial-results.htm

• US therapeutic: $488M (+14% QoQ, +92% YoY*)
• US cosmetic: $366M (+20% QoQ, +149% YoY*)
--
US total: $854M (57% therapeutic; 43% cosmetic) was 72% of worldwide total


• Ex-US therapeutic: $115M (+12 QoQ, +167% YoY*)
• Ex-US cosmetic: $218M (+27% QoQ, +176% YoY*)
--
Ex-US total: $333M (35% therapeutic; 65% cosmetic) was 28% of worldwide total


*YoY growth rates are exaggerated due to the effect of the pandemic during 2Q20.